Mirtazapine is widely regarded as one of the most sedating antidepressants available, so the idea that it could cause insomnia strikes most people as contradictory. Yet insomnia is a recognized side effect of the drug, one that appears in clinical use regardless of dose. The story is more nuanced than “sedating pill makes you sleepy,” involving everything from how your body adapts to the medication over time to secondary effects like restless legs and vivid nightmares that can fragment your sleep in ways that feel a lot like insomnia even if the drug itself is technically making you drowsy.
How Mirtazapine Usually Affects Sleep
To understand why insomnia from mirtazapine is surprising, you need to know what the drug typically does to sleep. In sleep-lab studies, the results are consistently pro-sleep. In healthy volunteers, mirtazapine improved sleep continuity compared with placebo, increasing sleep efficiency while cutting down on awakenings and the time spent awake during the night. It also boosted slow-wave sleep, the deep restorative stage, while reducing the lighter stage-1 sleep that leaves you feeling like you barely slept.1PubMed. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers In depressed patients, results were similar: mirtazapine cut sleep latency (how long it takes to fall asleep) and increased total sleep time and sleep efficiency within the first week of treatment.2PubMed. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study
A separate study in depressed patients confirmed that mirtazapine increased slow-wave sleep and reduced the time spent awake after initially falling asleep. It also raised REM latency and shortened the number of REM episodes, which in practical terms means more time in the deep, refreshing stages of sleep and less in the lighter, dream-heavy phases. Scores on the Athens Insomnia Scale dropped, meaning patients themselves felt they were sleeping better.3PubMed. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine A systematic review and meta-analysis of sedating antidepressants confirmed that mirtazapine significantly increased total sleep time, deep sleep as a proportion of total sleep, and sleep efficiency while reducing nighttime wakefulness.4PubMed. Management of insomnia symptoms in depressed patients treated with agomelatine, mirtazapine and trazodone: A systematic review and meta-analysis
In a head-to-head retrospective comparison with trazodone, another sedating antidepressant commonly used off-label for sleep, mirtazapine worked in roughly the same proportion of chronic insomnia patients. About 87% of people on either drug reported meaningful improvement, even at low doses, and the benefit appeared sustained over time without obvious tolerance developing.5PubMed. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study So the drug’s reputation as a powerful sleep aid is well earned. That makes the cases where it goes the other direction all the more puzzling.
Insomnia as a Direct Side Effect
Despite that strong sedating profile, insomnia shows up as an adverse effect in clinical data. An exploratory analysis of mirtazapine’s side effects found no association between the dose someone was taking and the likelihood of experiencing insomnia.6PubMed Central. Relationship between mirtazapine dose and incidence of adrenergic side effects: An exploratory analysis That finding is worth unpacking. It means insomnia was reported often enough to be included in the analysis alongside other recognized side effects like agitation, anxiety, and abnormal dreams. And the fact that it did not track with dose suggests the problem is not simply a matter of taking too much or too little. Some people just react differently to the drug.
Mirtazapine works through several receptor systems simultaneously. Its strong blockade of histamine H1 receptors is what produces the sedation most people experience, but it also blocks certain serotonin and adrenergic receptors. These secondary actions can increase norepinephrine activity in the brain, which is stimulating. In most people, the sedating histamine effect overwhelms the stimulating norepinephrine effect, especially at lower doses. But the balance between these competing actions varies from person to person depending on genetics, other medications, and individual receptor sensitivity. For a minority of users, the activating side wins out, and the result is difficulty sleeping.
Rebound Insomnia When Stopping Mirtazapine
A separate and arguably more common route to mirtazapine-related insomnia happens not while you are taking the drug but when you try to stop. Chronic blockade of histamine H1 receptors can trigger the brain to compensate by making its histamine signaling pathways more sensitive. While you keep taking the medication, this adaptation is masked. But when the drug is removed, the upregulated histamine system overshoots, leaving you more alert and wired than you were before you ever started the medication. The result is rebound insomnia that can be worse than whatever sleep problem the drug was originally prescribed for.7medRxiv. A Public Health Concern: The Rising Off-Label Use of Low-Dose Mirtazapine in Swedish Adolescents – Section: Rebound Insomnia and Dependency
This creates a dependency pattern that has been documented particularly among adolescents prescribed low-dose mirtazapine off-label for sleep. People continue the medication not because it is still doing much for their mood or their original sleep complaint, but because stopping it makes sleep worse. Clinical reports describe patients who try to taper, experience rebound insomnia, and restart the medication, cycling back and forth without ever getting cleanly off it. The effect is not well captured in standard clinical trials, which tend to be short, but it shows up repeatedly in real-world clinical practice.8medRxiv. A Public Health Concern: The Rising Off-Label Use of Low-Dose Mirtazapine in Swedish Adolescents – Section: Rebound Insomnia and Dependency
If you have been on mirtazapine for months or years and are considering stopping, a very gradual taper under medical supervision is the standard approach. Abruptly dropping the drug is far more likely to trigger this rebound. Even with a taper, some temporary sleep disruption is common, and it helps to know in advance that the insomnia you experience during withdrawal is a pharmacological rebound, not a sign that you “need” the drug permanently.
Restless Legs and Akathisia
Mirtazapine can also wreck your sleep indirectly by triggering movement-related problems you did not have before. In a controlled study of young healthy men, two-thirds developed periodic limb movements during sleep after their first dose of mirtazapine. These are involuntary leg jerks that occur throughout the night, disrupting sleep architecture even if you do not fully wake up. Three of the twelve subjects also reported restless legs symptoms. The periodic limb movements were worst on the first night and diminished over the following week, but for some individuals the effect persisted.9SLEEP. Mirtazapine Provokes Periodic Leg Movements during Sleep in Young Healthy Men
Then there is akathisia, a deeply uncomfortable sensation of inner restlessness that makes it impossible to sit or lie still. A case report described a woman who had been on mirtazapine for nearly 20 years when she developed intense inner restlessness, constant leg and foot movements, pacing, and insomnia. She also experienced significant distress and weight loss.10Clinical Neuropharmacology. Akathisia Induced by Mirtazapine After 20 Years of Continuous Treatment Akathisia is one of the most under-recognized side effects of many psychiatric medications, and when it strikes at night, the result looks and feels exactly like insomnia. The person cannot settle, cannot get comfortable, and may pace the house for hours. If your doctor does not think to ask about the quality of the restlessness, akathisia can be misdiagnosed as worsening anxiety or plain insomnia, leading to dose increases that make the problem worse.
The key takeaway here is that if your sleep worsened after starting or adjusting mirtazapine and the problem involves a physical urge to move your legs or an indescribable inner restlessness, the drug itself may be the culprit rather than your original condition.
Nightmares and Vivid Dreams
Some people on mirtazapine sleep through the night in a technical sense but wake feeling exhausted and distressed because of intense, disturbing dreams. One case report documented a young woman who developed severe nightmares on low-dose mirtazapine that were bad enough to require stopping the drug entirely.11PubMed Central. Low-Dose Mirtazapine-Induced Nightmares Necessitating its Discontinuation in a Young Adult Female The literature on mirtazapine’s effect on REM sleep, the stage where most vivid dreaming occurs, is inconsistent. Some studies show it suppresses certain REM parameters while boosting others. Unlike many antidepressants that strongly suppress REM sleep (which tends to reduce dreaming), mirtazapine lacks prominent REM-suppressant properties, leaving the door open for dream-heavy sleep that some people experience as distressing.
This is not the same thing as insomnia in the classical sense of lying awake unable to sleep. But from the patient’s perspective, the result is similar: you dread going to bed, you feel unrested in the morning, and your sleep feels broken even if a sleep tracker says you were technically asleep for eight hours. If nightmares are the main complaint, a dose adjustment or switch to a different medication is usually the solution, since this side effect is not something you can easily manage with sleep hygiene alone.
Manic Switching and Reduced Need for Sleep
In people with bipolar disorder or an unrecognized vulnerability to mania, mirtazapine can trigger a manic or hypomanic episode. One of the hallmark features of mania is a dramatically reduced need for sleep, where the person feels energized and wide awake on just a few hours. A case report described a patient who developed full manic symptoms around day 20 of mirtazapine treatment, including talkativeness, increased goal-directed activity, social disinhibition, and reduced need for sleep.12Malaysian Journal of Psychiatry. Manic Switch On Mirtazapine
A broader review of sedating antidepressants found that mirtazapine, trazodone, and agomelatine can all induce manic symptoms, though the risk is tied mainly to full antidepressant doses given without a mood stabilizer. At the low doses typically used for sleep, manic switching was observed only in patients who already had other risk factors.13PubMed. Low Risk for Switch to Mania during Treatment with Sleep Promoting Antidepressants Still, if you started mirtazapine and suddenly find yourself sleeping very little but feeling unusually energetic, productive, or impulsive, that pattern deserves urgent medical attention. It is not garden-variety insomnia. It may be a psychiatric emergency masquerading as a sleep problem.
Sleep-Related Eating Disorder
One of the stranger ways mirtazapine can disrupt sleep is by triggering nocturnal eating episodes. A case report described a patient started on mirtazapine for mood stabilization who, after her dose was increased to 30 mg, began binge eating during the night with only partial memory of the events on waking.14PubMed Central. Sleep-related eating disorder with mirtazapine Sleep-related eating disorder involves getting up to eat while in a partially conscious state. You may find wrappers and dirty dishes in the morning with little or no recollection of having eaten. Beyond the obvious nutritional and weight concerns, these episodes fragment sleep and leave you feeling groggy and unrefreshed.
Mirtazapine is already well known for increasing appetite and causing weight gain during waking hours, which is one of the most common reasons people discontinue it. The emergence of nighttime eating adds another layer. If you or a partner notice food going missing or signs of nocturnal kitchen activity you cannot remember, that is worth bringing up with your prescriber rather than attributing to stress or poor willpower.
Practical Guidance for Sorting Out the Problem
If you are on mirtazapine and struggling with sleep, the first step is identifying which of these pathways is actually at work. A few questions can help you and your doctor narrow it down:
- Timing: Did the insomnia start when you began the medication, after a dose change, or after you tried to stop? Onset insomnia with a new prescription points toward direct stimulation or akathisia. Insomnia after discontinuation points toward rebound. Insomnia after a dose increase may involve different receptor dynamics at higher doses.
- Character: Is it trouble falling asleep, staying asleep, or waking unrefreshed? Difficulty falling asleep suggests activation or restlessness. Frequent awakenings with leg movements suggest periodic limb movements. Feeling exhausted despite adequate hours in bed suggests nightmares or another sleep-quality issue.
- Restlessness: Do you feel an urge to move your legs, or an inner sense of agitation you cannot quite describe? That pattern strongly suggests akathisia or restless legs, both of which are medication side effects rather than primary insomnia.
- Mood changes: Are you sleeping less but feeling unusually energized? That raises concern for manic switching and needs prompt evaluation.
The dose-independence finding from clinical data means that simply lowering the dose is not a reliable fix for mirtazapine-related insomnia.15PubMed Central. Relationship between mirtazapine dose and incidence of adrenergic side effects: An exploratory analysis For some people, switching to a different medication is the only effective solution. For rebound insomnia during discontinuation, a slow taper over weeks to months is far better tolerated than an abrupt stop.
Why the Sedation Reputation Overshadows the Insomnia Risk
The reason most people, and even some prescribers, are surprised by mirtazapine-related insomnia is that the drug’s sedating effects are so dominant in most users that they define its clinical identity. In studies, the majority of patients report improved sleep, and the drug is frequently prescribed specifically to help with sleep, sometimes at low doses to someone who does not even have depression. The fact that roughly 87% of chronic insomnia patients improve on mirtazapine in comparative studies makes it easy to lose sight of the minority who do not.16PubMed. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study
Weight gain and sedation are the adverse effects that dominate clinical conversations about mirtazapine.17PubMed. Management of insomnia symptoms in depressed patients treated with agomelatine, mirtazapine and trazodone: A systematic review and meta-analysis Insomnia, restless legs, akathisia, and nightmares are less commonly discussed, partly because they are less common and partly because they seem to contradict the drug’s known mechanism. A patient who tells their doctor “mirtazapine is keeping me awake” may face skepticism, especially if the drug was prescribed to help them sleep in the first place. Knowing that these paradoxical reactions are documented in the medical literature can help you advocate for yourself if the standard narrative does not match your experience.

